Cite
MLA Citation
Ian E Krop et al.. “Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.” Lancet oncology, vol. 17, no. 6, n.d., pp. 811–821. http://access.bl.uk/ark:/81055/vdc_100032476377.0x00005a